Robert Duggan wins again as Summit lung cancer treatment beats Keytruda - STAT News

Summit Therapeutics' experimental drug outperformed Merck's Keytruda in non-small cell lung cancer, led by iconoclastic figure Bob Duggan, a billionaire with no drug industry experience.